Stock listing
Silexion Therapeutics Corp
Selected listing: SLXN · NASDAQ · USD · US
Silexion Therapeutics Corp (NASDAQ:SLXN), Health Technology. Latest release Sep 30, 2026: Silexion Therapeutics Announces First Patient Successfully Dosed…
- Ticker
- NASDAQ:SLXN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Silexion Therapeutics Corp
The company focuses on developing innovative therapeutic solutions. Investors can find relevant information about Silexion's operations and market performance on its dedicated public company page.
Latest news from Silexion Therapeutics Corp
Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
September 30, 2026
Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
September 29, 2026
Silexion Therapeutics Announces Exercise of Warrants
September 29, 2026
Silexion Therapeutics Announces Exercise of Warrants
September 28, 2026
Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers
September 28, 2026
Research Silexion Therapeutics Corp
Silexion Therapeutics Corp company profile
View the public company page for Silexion Therapeutics Corp on 6ix.
Silexion Therapeutics Corp news
Read company news and market updates connected to Silexion Therapeutics Corp.
Silexion Therapeutics Corp investor events
Find investor webinars, events, and replay context for Silexion Therapeutics Corp.